期刊档案 · 医学-化学综合
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
ISSN 0004-4172 · GERMANY · Monthly · 创刊 1951
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 订阅期刊，APC 约 3,620 美元，投稿社区反馈审稿4–8 周，录用比例容易（社区反馈），年发文 103 篇。
研究范围
研究范围与定位
Target ReadershipDrug Research is intended for scientists, clinicians, and professionals involved in drug discovery, drug development, translational medicine, pharmacology, toxicology, and the evaluation of therapeutic compounds. It serves researchers working with both novel and established drug molecules, as well as those engaged in clinical trials, industrial investigations, and the quantitative assessment of drug efficacy and safety.Journal Purpose and MissionDrug Research (formerly Arzneimittelforschung) is an international peer‑reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. The journal also addresses the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials.Types of Articles PublishedDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.Publication FrequencyDrug Research publishes 12 issues per annum.Subject and Content ScopeThe journal presents research related to novel and established drug molecules and the evaluation of new drug development. Its scope includes translational medicine and the application of biological discoveries to clinical drug development, as well as analytics applied to clinical trials, chemistry and biochemistry, clinical and experimental pharmacology, drug interactions, efficacy testing, pharmacodynamics, pharmacokinetics, teratology, and toxicology. It also encompasses the mathematical and statistical methods used to evaluate results from industrial investigations and clinical trials.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-化学综合
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Synthesis and biological activityChemistry10.8%
- Analytical Methods in PharmaceuticalsChemistry9.7%
- Antibiotics Pharmacokinetics and EfficacyMedicine7.6%
- Pharmaceutical studies and practicesMedicine5.9%
- Synthesis and Characterization of Heterocyclic CompoundsChemistry5.9%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.8%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance5.3%
- Synthesis and Biological EvaluationChemistry4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
收录数据库：暂无记录。
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 1.9出版商官网 ·
- h-index
- 57OpenAlex ·
- i10-index
- 618OpenAlex ·
- 两年平均被引
- 0OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
发文规模
- 年文章数
- 103LetPub ·
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
其他来源
- 平均审稿速度（社区反馈）
- 偏慢,4-8周LetPub ·
- 平均录用比例（社区反馈）
- 容易LetPub ·
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊LetPub
订阅期刊，文章需订阅或购买阅读，通常不收取版面费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | EUR 3,390 / USD 3,620 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型13 种
- commentariesC. Commentaries They usually follow the article that they discuss, have no special structure and are usually invited.未说明篇幅
- commentaryDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- controversiesD. Opinion Papers, Controversies The structure of these papers will vary from an original paper according to the nature of the topic and argument. Opinion paper…未说明篇幅
- letterDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- lettersF. Letters This article type has been introduced to encourage authors to engage in a free exchange of ideas.未说明篇幅
- opinionDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- opinion papersD. Opinion Papers, Controversies The structure of these papers will vary from an original paper according to the nature of the topic and argument. Opinion paper…未说明篇幅
- original articleDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- original articlesA. Original Articles Original papers should deal with investigations and results of high scientific value which have not been published previously.未说明篇幅
- reviewDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- reviewsB. Reviews Reviews deal with previous research on a certain topic and serve to summarize current findings on the topic so far.未说明篇幅
- short communicationDrug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.未说明篇幅
- short communicationsE. Short Communications Short Communications are completed projects of smaller scope and should contain new clinical and experimental data of immediate interest…未说明篇幅
官网政策摘录利益冲突、出版伦理、开放获取、预印本、试验注册 / 报告规范
- 利益冲突 Conflict of Interest
Conflict of interest declaration required for all authors during submission; failure may result in non-publication. 模型摘要
Please state the conflicts of interest of all authors during the online submission process. Failure to do so or an incomplete declaration may result in non-publication.
原文 ↗出版商官网 ·- 出版伦理
Ethics: proof of adherence to Declaration of Helsinki or local ethics committee approval for human research; compliance with Guide for the Care and Use of Laboratory Animals or ethics committee approval for animal research. 模型摘要
Please provide proof that the terms of the latest version of the “World Medical Association Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects” have been adhered to or provide approval of your local ethics committee.
原文 ↗出版商官网 ·- 开放获取 Publish Open Access
Hybrid Open Access available via APC payment; price list on Thieme website. 模型摘要
Authors of articles for all Thieme subscription journals – including, of course, Drug Research - have the option of paying an article processing charge (APC) so that their articles will be published on an Open Access basis. Learn more about Thieme’s Open Access program by visiting https://www.thieme.com/en-us/who-we-serve/authors/journals/open-access. For the current pricing, please go to “APC” an…
原文 ↗出版商官网 ·- 预印本 Preprint Server Statement
Preprints allowed (Research Square, arXiv, medRxiv, etc.); must note in cover letter, state updates, cite preprint with DOI; discouraged from depositing new versions until final decision; can update preprint 12 months after publication. 模型摘要
Drug Research encourages the submission of manuscripts that have been deposited in an initial draft version in preprint repositories such as Research Square, arXiv, and medRxiv. Drafts of short conference abstracts or degree theses posted on the website of the degree-granting institution, and draft manuscripts deposited on authors’ or institutional websites are also welcome. All other prior public…
原文 ↗出版商官网 ·- 试验注册 / 报告规范
Clinical trial registration required before recruitment of first subject; must be registered at an official registry recognised by ICMJE (e.g., ClinicalTrials.gov or WHO ICTRP primary registries). 模型摘要
Clinical trials must be registered before recruitment of the first subject.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版国家或地区
- GERMANY
- 出版周期
- Monthly
- 创刊年份
- 1951
- ISSN
- 0004-4172
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 的常见问题
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 的审稿周期多长？
投稿社区反馈的平均审稿速度为4–8 周，平均录用比例反馈为“容易”。文章统计只含被录用的稿件，社区反馈来自投稿者样本，均不代表期刊承诺。
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 是开放获取期刊吗？版面费多少？
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 为订阅期刊。APC 约 3,620 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。